The restrictions on practice by oncoplastic consultant Surgeon, Raafat Gendy placed by the Medical Practitioners Tribunal Service (MPTS) in May 2017 have been extended for a further period of eleven months and the investigation continues.
These restrictions apply until June 2018 and specify that:
‘except in life-threatening emergencies, he (Mr Gendy) must not carry out any breast cancer risk reduction surgery and must inform the GMC within seven days of any occasion he did carry out breast cancer risk reduction surgery in a life-threatening emergency. He must not carry out consultations with any patients regarding breast cancer risk reduction surgery.’
The action taken by the MPTS follows initial concerns that were raised about Mr Gendy’s treatment dating back to December 2015. The University Hospitals of North Midlands NHS Trust itself initiated an internal investigation in February 2016 after worries were expressed by members of the breast care team about the potential harm caused by Mr Gendy’s treatment of patients at The Royal Stoke University Hospital.
The Trust asked the Royal College of Surgeons to provide an independent external expert opinion and suspended the consultant from clinical duties from 22 January 2016. Subsequent to the extension of the restrictions placed on Mr Gendy’s practice by the MPTS, the Royal College of Surgeons recommended that a full investigation now takes place.
11 patients who have potentially been harmed have been contacted by the Trust to inform them of the Royal College of Surgeons second review.
Sharon Banga, an associate solicitor at Shoosmiths and Kashmir Uppal, a partner in the medical negligence team, remain concerned that not all affected patients may have been recalled. Indeed, some who attended a free advice clinic held by the law firm a year ago had to raise the issue themselves to ensure inclusion in the wider Trust investigation.
Kashmir Uppal, who also played a leading role in getting justice for the victims of convicted rogue breast surgeon Ian Paterson, said:
‘Unlike the Paterson case, I hope the investigation into these issues will be thorough, and if it identifies any failings and makes recommendations, that they are implemented effectively.’
In a statement issued by the University Hospitals of North Midlands NHS Trust on 25 October 2017, Dr John Oxtoby, Medical Director, said:
‘On behalf of the Trust I should like to express my sincere regret and apologies to any patients who may have received a standard of care that is below that expected. We took immediate action as soon as serious concerns about specific aspects of this consultant's practice were brought to our attention.’
On hearing the news of the extension of the restrictions imposed on his practice, Ms Glenys Matthews, one of Mr Gendy’s patients and now a Shoosmiths client, commented:
‘I am glad that the investigation appears to be being taken seriously, but I am still waiting for a substantive response from the Trust and I’m aware of other former patients of Mr Gendy who have also expressed concerns about the treatment they received from Mr Gendy who also await contact and reassurance.’
Anyone who has any concerns about the treatment they received from Mr Gendy prior to January 2016 can contact Kashmir Uppal on 03700 86 4375 or Sharon Banga on 03700 86 4061 for confidential advice about the options available.
For further information please contact: Allan Bisset
Phone: 03700 866736
Email: [email protected]